Evidence map›Paper›PMID 41735678›Full record

ReviewCellular and molecular neurobiology2026

D-serine: A Multitalented Neuromodulator in Brain Function, Systemic Homeostasis, and Disease.

Jing Wang, Yujin Guo, Wenxiu Han, Hailiang Zhang, Pei Jiang

Abstract readReview
In one paragraph

Review in Cellular and molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jing WangTranslational Pharmaceutical Laboratory, Shandong First Medical University, Jining No.1 People's Hospital, Jining, 272000, China.
Yujin GuoTranslational Pharmaceutical Laboratory, Shandong First Medical University, Jining No.1 People's Hospital, Jining, 272000, China.
Wenxiu HanTranslational Pharmaceutical Laboratory, Shandong First Medical University, Jining No.1 People's Hospital, Jining, 272000, China.
Hailiang ZhangTranslational Pharmaceutical Laboratory, Shandong First Medical University, Jining No.1 People's Hospital, Jining, 272000, China.
Pei JiangTranslational Pharmaceutical Laboratory, Shandong First Medical University, Jining No.1 People's Hospital, Jining, 272000, China. jiangpeicsu@sina.com.

Funding

National Natural Science Foundation of China 82202236National Natural Science Foundation of China 82204032National Natural Science Foundation of China 82272253National Natural Science Foundation of China 82501071Natural Science Foundation of Shandong Province ZR2023QH152the Key R&D Program of Jining 2023YXNS003the Key R&D Program of Jining 2023YXNS037
6 · The paper itself

Abstract

D-serine is an endogenous D-amino acid and a crucial co-agonist for the N-methyl-D-aspartate (NMDA) receptor, well known as a key regulator of synaptic plasticity, learning, and memory. This review summarizes recent advances that extend beyond this canonical role, positioning D-serine as a dynamic nexus linking brain function to systemic homeostasis. We explore its spatiotemporal dynamics in synaptic microdomains, sophisticated epigenetic and transcriptional regulation, and emerging role as a metabolic sensor linking cellular energetics to neuronal signaling. Furthermore, we highlight novel non-canonical signaling pathways, including its function as a ligand for the glutamate delta-1 receptor (GluD1) and its direct role in peripheral organs like the gut and kidney. The pathophysiological implications of disrupted D-serine homeostasis are detailed across a spectrum of CNS disorders—from schizophrenia and Alzheimer’s disease (AD) to addiction and neuropathic pain—as well as in peripheral conditions including diabetic complications and osteoporosis. Finally, we discuss the translational potential of targeting D-serine pathways through innovative therapeutic strategies—such as serine racemase (SR) modulators, D-amino acid oxidase (DAAO) inhibitors, and gene therapy—and its promise as a biomarker for personalized medicine in neurology and psychiatry.

Indexed as

BrainHomeostasisNeurotransmitter AgentsSerineAnimalsHumansSerine RacemaseSignal TransductionNeurotransmitter AgentsSerineSerine RacemaseD-serineMetabolic sensorNeuromodulationNMDA receptorSynaptic plasticityTherapeutic target

Identifiers

PMID41735678
PMCPMC12992856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.